Worldwide Reach, Local Insight
With nearly three decades of gastrointestinal leadership and a proven international infrastructure, we support programs that span continents, require diverse patient populations, and demand consistent performance across regions:
- 30+ years as the global GI CRO
- Trusted for 70% of IBD compounds in development
- Proven site selection strategy with 20% fewer non-screening sites
- Specialized GI operational teams with deep regional expertise
- Consistent global delivery model with centralized oversight and local execution
Our teams combine international scale with country specific regulatory and cultural understanding to reduce friction and speed activation.
Long-standing site relationships strengthen recruitment, quality, and operational reliability across our global network.
Our Global Presence
Our network of 5,000+ GI research sites in more than 60 countries allows sponsors to expand seamlessly into new markets while benefiting from unified processes, centralized oversight, and local insights.
North America
- Canada
- Dominican Republic
- Mexico
- United States
South America
- Argentina
- Brazil
- Chile
- Colombia
Europe
- Austria
- Belgium
- Bosnia and Herzegovina
- Bulgaria
- Croatia
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Ireland
- Italy
- Latvia
- Lithuania
- Moldova
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- UK
- Ukraine
Africa
- Egypt
- Morocco
- South Africa
Oceania
- Australia
Asia
- Armenia
- China
- Georgia
- Hong Kong
- India
- Israel
- Japan
- Jordan
- Kazakhstan
- Lebanon
- Malaysia
- Philippines
- Saudi Arabia
- Singapore
- South Korea
- Taiwan
- Thailand
- Turkey
- United Arab Emirates (UAE)
- Vietnam